on completely old story does anyone has a valid login for ADIS Insight. Love to get the full story, because the front page does not make any sense.
Most Recent Events
06 Mar 2018Efficacy and adverse events data from the phase Ib CEP-1 trial in Solid tumours presented at the European Society for Medical Oncology Congress - 2018 (ESMO-2018).
22 Jan 2018Kazia Therapeutics has intellectual property protection for idronoxil novel formulation
27 Dec 2017Kazia Therapeutics acquires idronoxil novel formulation from Noxopharm